Patient perceptions of pharmacogenomic testing in the community pharmacy setting
| Autor: | Marcia M. Worley, David R. Bright, Brianne L. Porter |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
medicine.medical_specialty Pharmaceutical Science Pharmacogenomic Testing Context (language use) Pharmacy Pharmacists 030226 pharmacology & pharmacy law.invention 03 medical and health sciences 0302 clinical medicine law Health care medicine Humans Pharmacies Third party business.industry Theory of planned behavior Patient perceptions Community pharmacy Pharmacogenetics 030220 oncology & carcinogenesis Family medicine CLARITY Perception Psychology business |
| Zdroj: | Research in socialadministrative pharmacy : RSAP. 17(4) |
| ISSN: | 1934-8150 |
| Popis: | Background In order to optimize community pharmacist roles and patient outcomes, a better understanding of patient perceptions of pharmacogenomic (PGx) testing may be helpful for successful integration into community pharmacy practice. Objective The objective of this study was to identify patient perceptions related to PGx testing in the community pharmacy setting. Methods Semi-structured, face-to-face interviews were conducted with adults ≥18 years of age to gather their perceptions of PGx testing. Interview participants were taking either an antiplatelet agent or a selective serotonin reuptake inhibitor listed in Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines and were patients at one of two community pharmacies in West Michigan. Interview questions were designed to follow the Theory of Planned Behavior and to take into account existing literature on patient perceptions of PGx. Interviews were recorded, transcribed by a third party transcription service, coded by a team of three researchers to identify themes, and analyzed using nVivo qualitative analysis software. Results A total of 19 interviews were conducted over a period of 16 days in June 2016. Upon preliminary evaluation, four themes related to patient perceptions of PGx testing were consistently observed across multiple interviews: 1) trust, 2) experience, 3) risk/benefit, and 4) clarity. Conclusions Semi-structured patient interviews revealed four themes related to PGx testing in the community pharmacy setting. These themes may influence the desire to pursue PGx testing. Future research may seek to identify how community pharmacists can communicate with patients about PGx in the context of these themes to empower patients to make positive health care decisions. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect